9: Headaches

CHAPTER 9 Headaches


Headaches are one of the most common pain conditions for which medical attention is sought. Headaches are typically classified as primary or secondary. Primary headache disorders include migraine (see Chapter 10), tension-type headache, and cluster headache. Secondary headaches result from other organic disturbances such as infections and metabolic disorders.


Although most headaches are not serious, some signal dangerous medical conditions such as cerebral aneurysm, brain tumor, stroke, meningitis, or encephalitis. A severe headache that comes on suddenly—especially if it is accompanied by numbness, loss of consciousness, dizziness, slurred speech, seizures, or fever—must be evaluated immediately by an appropriately trained medical professional.



TENSION-TYPE HEADACHES


An estimated 88% of women and 69% of men experience a tension-type headache sometime during their lifetimes.1 Approximately 820 workdays are lost annually for every 1000 persons as a result of tension-type headaches,2 compared with 270 days lost annually per 1000 persons as a result of migraines. More than 45 million Americans live with chronic recurrent headaches. For some, these headaches are simply a nuisance; for others, tension-type headaches create a significant reduction in their quality of life.


It is estimated that only 15% of people who experience tension-type headaches seek medical attention (see “Self-Help Ideas for Handling Headaches”). This may be due in part to the very nature of the name tension-type headache. This term has fostered the widely held belief that this type of headache is purely psychological in nature. This chapter provides a discussion of the physiologic basis, diagnosis, and treatment of tension-type headaches.




SELF-HELP IDEAS FOR HANDLING HEADACHES


During times of heightened stress, the number and severity of headaches may increase. Several self-care strategies are useful in obtaining relief from headache pain.













Physiologic Basis


Although the tension-type headache is the most common type of head pain, its physiologic basis remains unclear. It is been thought for many years that tension-type headaches are muscular in origin because myofascial pain tends to be dull and achy, poorly localized, and radiating, whereas pain originating from cutaneous structures is normally sharp, localized, and nonradiating. Increased myofascial tenderness and muscle firmness are two of the most prominent abnormal findings in patients with chronic tension-type headache.3,4 What causes and sustains this muscle firmness and myofascial tendernesshas become a matter of debate. From the findings of experimental research and clinical studies it appears that myofascial nociception is a key component of episodic tension-type headache; however, central sensitization appears to predominate in the chronic form.5 (Nociception refers to the detection of noxious stimuli by the nervous sytem. The receptors involved in pain detection are referred to as nociceptors.) Central sensitization is best described as an increased excitability of central nervous system neurons that results from prolonged nociceptive input from the periphery. Central sensitization has been shown to play a significant role in chronic myofascial pain.6 Increased tenderness in patients with chronic tension-type headaches may be a result of sensitization of spinal dorsal-horn neurons induced by prolonged sensory input from pericranial myofascial tissues.7



Role of nitric oxide.


Nitric oxide (NO) is involved in the development of central sensitization8 and nitric oxide synthase (NOS) inhibitors, which reduce the level of NO, also have been shown to reduce central sensitization in animal studies of persistent pain.9,10 In light of these data, the role of NO as a mediator in tension-type headaches is being explored. Inhibition of NO was found to effectively reduce both pain and muscle firmness in a small randomized double-blind crossover study of 16 patients with chronic tension-type headaches. Patients were administered intravenous infusions of 6 mg/kg L-NMMA (NG-monomethyl-L-arginine hydrochloride, an inhibitor of NOS) or placebo for 2 days, separated by at least 1 week, in a randomized fashion. Headache intensity was measured on a 100-mm visual-analog scale at baseline and 30, 60, and 120 minutes after start of treatment. L-NMMA reduced pain intensity significantly more than did placebo (P = 0.01).11,12




Evaluation and Diagnosis


A thorough history and physical examination should be undertaken for the evaluation of headache. The history should include appropriate exploration of secondary causes of headache, including depression, medication (prescription and over-the-counter [OTC]), substance abuse, and neurological disorders. It is essential that the provider determine whether the headaches are episodic or chronic because the clinical management will differ accordingly.


The physical examination should include a comprehensive neurologic evaluation that includes observation for cranial nerve defects, cerebellar dysfunction, papilledema, absence of venous pulsation on fundoscopic examination, visual-field defects, and motor and sensory deficits. Abnormal findings could indicate intracranial irregularitis, and appropriate diagnostic studies should be performed before a definitive diagnosis of tension-type headache is made. The following recommendations were proposed as diagnostic criteria for neuroimaging: focal neurologic finding on physical examination, headache starting after exertion or Valsalva’s maneuver, acute onset of severe headache, headache awakens patient at night, change in well-established headache pattern, new-onset headache in a patient older than 35 years, and new-onset headache in a patient who has human immunodeficiency virus infection or a previously diagnosed cancer.16


Careful palpation of the head in a patient with tension-type headache often reveals tenderness in the pericranial muscles, the occipital region, and the trapezius. Palpation of the temporomandibular joint should also be performed, as this joint is often involved in the development of headaches.



Nov 4, 2016 | Posted by in OBSTETRICS | Comments Off on 9: Headaches

Full access? Get Clinical Tree

Get Clinical Tree app for offline access